Dipivefrine
From Wikipedia, the free encyclopedia
(Redirected from Dipivefrin)
|
|
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (February 2008) |
| Systematic (IUPAC) name | |
|---|---|
| [2-(2,2-dimethylpropanoyloxy)-4- (1-hydroxy-2-methylamino-ethyl)- phenyl] 2,2-dimethylpropanoate | |
| Identifiers | |
| CAS number | 52365-63-6 |
| ATC code | S01EA02 |
| PubChem | 3105 |
| DrugBank | APRD00930 |
| ChemSpider | 2994 |
| Chemical data | |
| Formula | C19H29NO5 |
| Mol. mass | 351.437 g/mol |
| SMILES | eMolecules & PubChem |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
B(US) |
| Legal status | |
| Routes | ? |
| |
|
Dipivefrine (Dipivefrin in the United States) is a prodrug of adrenaline, which is used to treat glaucoma. It is available as ophthalmic solution . It causes vasoconstriction, decreased aqueous humor production, and decreases intraoccular pressure. It gets converted to epinephrine upon penetrating the cornea.
|
||||||||||||||||||||||||||||
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |